Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Nutex Health (NUTX) Net Cash Flow (2016 - 2026)

Nutex Health (NUTX) has disclosed Net Cash Flow for 17 consecutive years, with $24.8 million as the latest value for Q1 2026.

For Q1 2026, Net Cash Flow fell 43.82% year-over-year to $24.8 million; the TTM value through Mar 2026 reached $125.6 million, up 129.54%, while the annual FY2025 figure was $144.9 million, 677.63% up from the prior year.
Net Cash Flow hit $24.8 million in Q1 2026 for Nutex Health, up from $19.5 million in the prior quarter.
Across five years, Net Cash Flow topped out at $69.3 million in Q3 2025 and bottomed at -$11.0 million in Q3 2022.
Average Net Cash Flow over 5 years is $10.2 million, with a median of $6.1 million recorded in 2024.
Year-over-year, Net Cash Flow crashed 225.83% in 2022 and then surged 13240.32% in 2024.
Nutex Health's Net Cash Flow stood at -$2.4 million in 2022, then tumbled by 103.95% to -$4.8 million in 2023, then decreased by 29.92% to -$6.3 million in 2024, then soared by 411.52% to $19.5 million in 2025, then grew by 26.85% to $24.8 million in 2026.
According to Business Quant data, Net Cash Flow over the past three periods came in at $24.8 million, $19.5 million, and $69.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.